News
TEVA
31.15
+1.07%
0.33
Quant check on David Einhorn's Greenlight Capital holdings post Q1
Seeking Alpha · 1h ago
Teva: The Market Is Pricing The Past, Not The Pipeline - Initiating Buy
Seeking Alpha · 10h ago
Teva must face Mylan lawsuit over generic competition for Copaxone
Reuters · 16h ago
Does Biosimilar Wins in Osteoporosis and Allergy Care Change The Bull Case For Teva (TEVA)?
Simply Wall St · 20h ago
Weekly Report: what happened at TEVA last week (0406-0410)?
Weekly Report · 1d ago
A Look At Teva Pharmaceutical Industries (TEVA) Valuation After Recent Biosimilar Regulatory Milestones
Simply Wall St · 3d ago
Teva Pharmaceuticals Is Maintained at Buy by B of A Securities
Dow Jones · 4d ago
Teva Pharmaceuticals Price Target Raised to $42.00/Share From $38.00 by B of A Securities
Dow Jones · 4d ago
B of A Securities Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $42
Benzinga · 4d ago
Analysts Are Bullish on These Healthcare Stocks: InflaRx (IFRX), Teva Pharmaceutical (TEVA)
TipRanks · 4d ago
Teva price target raised to $42 from $38 at BofA
TipRanks · 4d ago
Notable ETF Inflow Detected - ACWX, SPOT, TEVA, SUNB
NASDAQ · 5d ago
Abeona appoints Syndax CFO Keith Goldan to board as audit committee chair
Reuters · 6d ago
Weekly Report: what happened at TEVA last week (0330-0403)?
Weekly Report · 04/06 09:09
How Investors Are Reacting To Teva (TEVA) Advancing Its Biosimilar Pipeline With New FDA and EMA Milestones
Simply Wall St · 04/04 07:17
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
NASDAQ · 04/03 09:10
Assessing Teva Pharmaceutical Industries (TEVA) Valuation After New Biosimilar Approvals And Pipeline Progress
Simply Wall St · 04/02 16:31
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Nuvation Bio (NUVB) and Argenx Se (ARGX)
TipRanks · 04/02 12:20
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda
Benzinga · 04/01 17:36
Missile Strike Tests Teva Supply Resilience And Biosimilar Growth Plans
Simply Wall St · 04/01 13:31
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.